Symptoms and General Pathology

All Conditions

Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Gland and Hormone Related Diseases

Syndrome

Polycystic Ovary Syndrome

Anovulation

Cysts

Ovarian Cysts

Ovarian Diseases

Adnexal Diseases

Genital Diseases, Female

Genital Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Gonadal Disorders

Endocrine System Diseases

Hypoglycemic Agents

All Drugs and Chemicals

Micronutrients

Hematinics

Vitamins

Metformin

Folic Acid

Vitamin B Complex

Folinic Acid

Folate

Vitamin B9

A six-month course of metformin (1700 mg daily) plus folic acid (400 microgram daily).

Folate plus metformin

A six-month course of metformin (1700 mg daily) plus placebo

Placebo plus metformin

Context: Metformin administration in women with polycystic ovary syndrome (PCOS) improves hormonal and metabolic patterns with beneficial effects in terms of reproductive outcomes and intermediate cardiovascular disease risk factors. Furthermore, reduced folate and vitamin B12, and increased homocysteine (Hcy) levels have been found in type-2 diabetes mellitus patients treated with metformin.

Objective: To evaluate if metformin administration exerts any effects on Hcy levels, and if folate supplementation may improve endothelial structure and function in PCOS patients.

Fifty patients affected by PCOS without additional metabolic or cardiovascular diseases grouped in two age- and body mass index-matched treatment arms.

Interventions: A six-month course of metformin (1700 mg daily) plus folic acid (400 microgram daily) (experimental group, n=25) or placebo (control group, n=25) supplementation.

In each patient were evaluated: Complete hormonal and metabolic patterns, serum Hcy, folate, vitamin B12, and endothelin-1 (ET-1) concentrations, brachial artery diameter at baseline (BAD-B) and after reactive hyperemia (BAD-RH), flow-mediated dilation (FMD), and intima-media thickness (IMT) on both common carotid arteries.

Metformin and Folate Supplementation in Polycystic Ovary Syndrome (PCOS) Patients

Effects of Metformin With or Without Folate Supplementation on Homocysteine Levels and Endothelium in Women With Polycystic Ovary Syndrome

University Magna Graecia

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Metformin and Folate Supplementation in Polycystic Ovary Syndrome (PCOS) Patients	NCT00953355	Polycystic Ovar... Anovulation	Folate plus met... Placebo plus me...	18 Years - 35 Years	University Magna Graecia
Metformin and Folate Supplementation in Polycystic Ovary Syndrome (PCOS) Patients	NCT00953355	Polycystic Ovar... Anovulation	Folate plus met... Placebo plus me...	18 Years - 35 Years	University Magna Graecia

Spots Global Cancer Trial Database for placebo plus metformin